Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
The partnership, which includes the city fire department, will use $1.3 million in grants to address substance abuse and addiction
The paramedic reportedly admitted to stealing six oxycodone pills while at work
The Womanikin attachment seeks to make civilians more comfortable performing CPR on women
The dedicated wing would include space to treat up to 50 first responders and include specialized care
We are beginning to see the initial correlations with COPD that vaping has on our patients’ overall health and respiratory disease exacerbation
Police say the man regained consciousness after being giving naloxone and immediately began striking first responders
Colin Andrew Davis was sentenced to six months in prison for tampering with fentanyl and ketamine vials
Test your knowledge of different types of airway adjuncts, contraindications, monitoring techniques and more
Police say Raymond Kibby stole the ambulance from outside the hospital where he was receiving treatment for heroin withdrawal
The device is implanted under the skin and automatically releases naloxone when it detects a drop in blood-oxygen level
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.